What are the top 3 AI drug discovery companies in the world?

The top 3 AI drug discovery companies in the world are:

1. **Insilico**: This company is recognized for its AI platform, Pharma.AI, which is used to address various diseases including cancer, dermatological conditions, fibrosis, Parkinson’s Disease, Alzheimer’s Disease, ALS, diabetes, sarcopenia, and aging. Insilico has been involved in internal drug discovery ventures and has taken a lead in AI-driven drug discovery. Notably, their AI-generated drug candidate has entered human trials, marking a significant milestone in the industry.
2. **BenevolentAI**: Founded in 2013, BenevolentAI has made notable contributions to AI-driven drug discovery. The company has a partnership with AstraZeneca for developing drugs for fibrosis and chronic kidney disease. BenevolentAI's platform, Knowledge Graph, has been used for drug repurposing, as seen in the rediscovery of baricitinib for COVID-19 treatment. The company has also been recognized for its AI capabilities in drug discovery and has an estimated valuation of around $2.4 billion.
3. **Atomwise**: Atomwise is known for its AI platform, AtomNet, which has been shown to be a viable alternative to high-throughput screening. The company has collaborations with several pharmaceutical giants, including Sanofi, and has signed significant research collaborations that leverage its AtomNet platform for computational discovery and research of drug targets.

These companies are at the forefront of AI drug discovery, leveraging advanced technologies to improve the efficiency and effectiveness of the drug development process.